SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1415161718192021Next Page
2026-07-15SVA6-KSinovac Extends Submission Deadline for $55.00 Special Cash Dividend to December 2026MEDIUM
On July 15, 2026, Sinovac Biotech Ltd. (NASDAQ: SVA) announced a second extension for the deadline to submit payment instructions regarding its previously declared special cash dividend. The special dividend of $55.00 per common share is payable to shareholders of record as of May 23, 2025. Originally, the company requ...
BiotechnologyOthers
2026-07-15SPRC6-KSciSparc Subsidiary NeuroThera Labs Initiates Phase IIb Trial of SCI-110 for Tourette Syndrome in GermanyMEDIUM
On July 15, 2026, SciSparc Ltd. announced that its subsidiary, NeuroThera Labs Inc., has initiated a Phase IIb clinical trial site at Hannover Medical School in Germany for SCI-110, a proprietary cannabinoid-based treatment for Tourette Syndrome (TS) in adults. SCI-110 is a combination of dronabinol and palmitoylethano...
Nano CapBiotechnologyTrial Initiation
Previous Page1415161718192021Next Page